Publications (503) MANUEL PRAGA TERENTE publications

filter_list

2025

  1. A predicting tool for kidney function recovery after drug-induced acute interstitial nephritis

    Nephrology Dialysis Transplantation, Vol. 40, Núm. 9, pp. 1707-1716

  2. A predictive model of non-diabetic kidney disease in patients with diabetes mellitus and chronic kidney disease. A Spanish multi-center study

    Nefrologia, Vol. 45, Núm. 5, pp. 360-368

  3. Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression

    Clinical Journal of the American Society of Nephrology, Vol. 20, Núm. 5, pp. 632-641

  4. Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative GN

    Clinical Journal of the American Society of Nephrology, Vol. 20, Núm. 8, pp. 1119-1131

  5. Comparative Analysis of Proteinuria and Longitudinal Outcomes in Immune Complex Membranoproliferative Glomerulonephritis and C3 Glomerulopathy

    Kidney International Reports, Vol. 10, Núm. 4, pp. 1223-1236

  6. Comparative Analysis of Proteinuria and Longitudinal Outcomes in Immune Complex Membranoproliferative Glomerulonephritis and C3 Glomerulopathy

    Kidney International Reports, Vol. 10, Núm. 4, pp. 1223-1236

  7. Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial

    Rheumatology, Vol. 64, Núm. 6, pp. 3863-3871

  8. Hydroxychloroquine for Proteinuria Control in Pregnant Patients With IgA Nephropathy

    Kidney International Reports, Vol. 10, Núm. 10, pp. 3685-3688

  9. Identification of early predictors of clinical remission in primary membranous nephropathy: a post hoc analysis of the STARMEN trial

    Clinical Kidney Journal, Vol. 18, Núm. 9

  10. Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 Glomerulopathy

    Kidney International Reports, Vol. 10, Núm. 2, pp. 432-446

  11. Management of Acute Tubulointerstitial Nephritis

    Advances in Kidney Disease and Health, Vol. 32, Núm. 4, pp. 373-381

  12. Predicting Remission in Antiphospholipase A2 Receptor Antibody-Associated Membranous Nephropathy A Secondary Analysis of the GEMRITUX, MENTOR, and STARMEN Trials

    Clinical Journal of the American Society of Nephrology, Vol. 20, Núm. 6, pp. 854-865

  13. Tailored management strategies for IgA nephropathy based on clinical presentations

    Nephrology Dialysis Transplantation, Vol. 40, Núm. 5, pp. 874-883

2024

  1. Apolipoprotein E in dense deposits: a parting of the ways in C3 glomerulopathy

    Clinical Kidney Journal, Vol. 17, Núm. 6

  2. Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis

    Kidney International, Vol. 105, Núm. 1, pp. 177-188

  3. Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 8, pp. 1288-1298

  4. Developing Therapies for C3 Glomerulopathy Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group

    Clinical Journal of the American Society of Nephrology, Vol. 19, Núm. 9, pp. 1201-1208

  5. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy

    Kidney International, Vol. 105, Núm. 6, pp. 1279-1290

  6. Microscopic hematuria in C3G and IC-MPGN

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 9, pp. 1529-1532

  7. Nefropatías glomerulares primarias

    Medicina interna (Elsevier España), pp. 894-904